6.83  -0.36 (-5.01%)		10-30 16:00
Open: 7.135 High: 7.24 Volume: 1,376,722		Pre. Close: 7.19 Low: 6.57 Market Cap: 703(M)

Short term
Mid term
Targets	6-month :	8.75	1-year :	9.67
Resists	First :	7.49	Second :	8.27
Pivot price	6.75
Supports	First :	6.21	Second :	5.17
MAs	MA(5) :	6.86	MA(20) :	6.86
	MA(100) :	6.87	MA(250) :	5.45
MACD	MACD :	-0.2	Signal :	-0.3
%K %D	K(14,3) :	58.8	D(3) :	54.6
RSI	RSI(14): 46.4
52-week	High :	8.64	Low :	2.61

Price has closed below its short-term moving average. Short-term moving average is currently below mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is BEARISH in short-term; and NEUTRAL in mid-long term.
[ ACHV ] has closed below upper band by 42.9%. Bollinger Bands are 28.4% narrower than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.

If tomorrow:	Open lower	Open higher
High:	7.25 - 7.29	7.29 - 7.32
Low:	6.49 - 6.53	6.53 - 6.56
Close:	6.78 - 6.83	6.83 - 6.88

Achieve Life Sciences, Inc. operates as a clinical-stage pharmaceutical firm, concentrating on the development and market introduction of cytisinicline. This compound is aimed at assisting with smoking cessation and nicotine dependence, with commercial activities spanning Canada, the United States, and the United Kingdom. Cytisinicline is a naturally occurring alkaloid, which functions by engaging with nicotine receptors in the brain to lessen the intensity of nicotine withdrawal symptoms. The company holds licensing agreements with Sopharma AD and the University of Bristol. Its corporate headquarters are located in Vancouver, Canada.

Wed, 21 Oct 2026
After an inactive-treatment trial, 39.4% of those still smoking or vaping had quit by the final month. - Stock Titan

Fri, 16 Oct 2026
Achieve Life Sciences (NASDAQ:ACHV) Stock Falls 6% - Should You Sell? - MarketBeat

Fri, 16 Oct 2026
Achieve Life Sciences, Inc. (ACHV) - What Are Investment Firms Saying About This Stock? - MarketBeat

Wed, 23 Sep 2026
Achieve Life Sciences: Thesis Intact, Setup Remains Constructive (Rating Downgrade) (ACHV) - Seeking Alpha

Fri, 14 Aug 2026
Achieve Life Sciences, Inc. (NASDAQ:ACHV): Is Breakeven Near? - Simply Wall St

Fri, 14 Aug 2026
Achieve Life Sciences, Inc. (NASDAQ:ACHV): When Will It Breakeven? - Moomoo

Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly.	Underperform
Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS).	Underperform
Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows.	Underperform
Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit.	Underperform
Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency.	Outperform
Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn.	Underperform

Exchange: NASDAQ
Sector: Healthcare
Industry: Biotechnology
Shares Out	103 (M)
Shares Float	75 (M)
Held by Insiders	0.9 (%)
Held by Institutions	82.2 (%)
Shares Short	17,470 (K)
Shares Short P.Month	16,450 (K)

EPS	-1.7
EPS Est Next Qtrly	0
EPS Est This Year	0
EPS Est Next Year	0
Book Value (p.s.)	-0.15
Profit Margin	0 %
Operating Margin	0 %
Return on Assets (ttm)	-29.3 %
Return on Equity (ttm)	-845 %
Qtrly Rev. Growth	0 %
Gross Profit (p.s.)	0
Sales Per Share	0
EBITDA (p.s.)	-0.57
Qtrly Earnings Growth	0 %
Operating Cash Flow	-47 (M)
Levered Free Cash Flow	156 (M)

PE Ratio	-4.05
PEG Ratio	17.6
Price to Book value	-48.79
Price to Sales	0
Price to Cash Flow	-14.98

Dividend	0
Forward Dividend	0
Dividend Yield	0%
Dividend Pay Date	Invalid DateTime.
Ex-Dividend Date	Invalid DateTime.